The so-called NewCo model of value creation has been around for years, but its use with assets connected to China appears to be increasing, as the world’s second-most populous country experiences a renaissance in its drug development industry.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.